San Diego, CA, United States of America

Rachel Schowalter

This inventor holds 2 USPTO granted patents. Top assignee: Jpmorgan Chase Bank, N.a.. Active years: 2025.


% Patents Active = 100.0

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Rachel Schowalter: Innovator in Endonuclease Assays

Introduction

Rachel Schowalter is a prominent inventor based in San Diego, CA. She has made significant contributions to the field of biotechnology, particularly in the development of endonuclease assays. With a total of 2 patents to her name, Rachel is recognized for her innovative approaches to complex scientific challenges.

Latest Patents

Rachel's latest patents include the "Encoded Dual-Probe Endonuclease Assays" and "Encoded Endonuclease Assays." These inventions represent a leap forward in the efficiency and accuracy of genetic testing and analysis.

Career Highlights

Rachel currently works at JPMorgan Chase Bank, N.A., where she applies her expertise in innovative technologies. Her work has garnered attention for its potential applications in various sectors, including healthcare and finance.

Collaborations

Throughout her career, Rachel has collaborated with notable professionals in her field, including Jeffrey Brodin and Lorenzo Berti. These partnerships have enhanced her research and contributed to the success of her inventions.

Conclusion

Rachel Schowalter stands out as a talented inventor whose work in endonuclease assays is paving the way for advancements in biotechnology. Her contributions are not only valuable to her field but also demonstrate the impact of innovation on society.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…